Assessment of the influence of the inflammatory process on the activation of blood platelets and morphological parameters in patients with ulcerative colitis (Colitis ulcerosa)

Folia Histochemica et Cytobiologica

Volumn 49, Issue 1, 2011, Pages 119-124

  Polińska, Beata ^a   Matowicka Karna, Joanna ^a   Kemona, Halina ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Blood platelets; IL 6; Mean platelet volume (MPV); Soluble P selectin; Ulcerative colitis

Indexed keywords

INTERLEUKIN 6; PADGEM PROTEIN;

ADULT; ARTICLE; CELL STRUCTURE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; STRUCTURE ANALYSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; ULCERATIVE COLITIS;

MOROCCAN PEPPER VIRUS;

EID: 79958107513     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2011.0017     Document Type: Article

References (25)

1. Irving PM, Macey MG, Feakins RM et al. Platelet-leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitis. Eur J Gastroenterol Hepatol. 2008;20:283-289.
2. +/ /forkhead box protein-P3+ in patients with ulcerative colitis during active and quiescent disease. Clin Exp Immunol. 2009;156:320-327.
3. Gutkowski K, Gutkowska D. Rola mechanizmów immuno-logicznych w patogenezie nieswoistych zapalnych chorób jelit. Gastroenterol Pol. 2006;13:197-201.
4. Polińska B, Matowicka-Karna J, Kemona H. Cytokiny wnie-swoistych zapalnych chorobach jelit. Poste{ogonek}py Med Hig Dośw (online). 2009;63:389-394.
5. Cakal B, Akoz AG, Ustundag Y et al. Red cell distribution width for assessment of activity of inflammatory bowel disease. Dig Dis Sci. 2009;54:842-847.
6. Yüksel O, Helvaci K, Başar O et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets. 2009;20:277-281.
7. Larsen TB, Nielsen JN, Fredholm L et al. Platelets and anticoagulant capacity in patients with inflammatory bowel disease. Pathophysiol Haemost Thromb. 2002;32:92-96.
8. Grivennikov S, Mucida D, Terzic J et al. The role of IL-6 and IL-23 in colitis associated cancer. J Immunol. 2009; 182:30.
9. Kwon KH, Murakami A, Hayashi R. Interleukin-1beta targets interleukin-6 progressing dextran sulfate sodium-induced experimental colitis. Biochem Biophys Res Commun. 2005;337:645-654.
10. Naito Y, Takagi T, Uchiyama K et al. Reduced intestinal inflammation induced by dextran sodium sulfate in interleu-kin-6-deficient mice. Int J Mol Med. 2004;14:191-196.
11. Pamuk GE, Vural O, Turgut B et al. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Am J Hematol. 2006;81:753-759.
12. Grove EL, Hvas AM, Kristensen SD. Immature platelets in patients with acute coronary syndromes. Thromb Haemost. 2009;101:151-156.
13. Kralisz M, Matowicka-Karna J. Ocena parametrów morfo-logicznych płytek krwi w przebiegu giardiazy. Pol Merk Lek. 2008;150:480-483.
14. Matowicka-Karna J, Kemona H. Aktywność fagocytarna płytek krwi w przebiegu różnych chorób pasożytniczych. Przegla{ogonek}d Lekarski. 2002;59:820-822.
15. Ranjith M P, Divya R, Mehta VK et al. Significance of platelet volume indices and platelet count in ischaemic heart disease. J Clin Pathol. 2009;62:830-833.
16. Sobecka K, Mantur M, Sidorska A. Ste{ogonek}żenie b-TG i sP-selek-tyny w pierwotnym raku nerki. Diagn Lab. 2007;43:183-190.
17. Ay C, Jungbauer LV, Sailer T et al. High concentrations of soluble P-selectin are associated with risk of venous throm-boembolism and the P-selectin Thr715 variant. Clin Chem. 2007;53:1235-1243.
18. Fägerstam J P, Whiss PA. Higer platelet P-selectin in male patients with inflammatory bowel disease compared to healthy males. Word J Gastroenterol. 2006;12:1270-1272.
19. Mantur M, Kemona H, Kozłowski R, Kemona-Chetnik I. Effect of tumor stage and nephrectomy on CD62P expression and sP-selectin concentration in renal cancer. Neoplas-ma. 2003;50:262-265.
20. Wedrychowicz A, Stopyrowa J, Fyderek K. Serum and stool interleukin 6 in active and inactive ulcerative colitis in children. Pediatr Wsp Gastroenterol Hepatol i Żywienie Dziecka. 2000;13:165-169.
21. Raddatz D, Bockemühl M, Ramadori G. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol. 2005;17:547-557.
22. Bancroft AJ, Abel E W, McLaren M et al. Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets. 2000;11:379-387.
23. Lippi G, Filippozzi L, Salvagno GL et al. Increased mean platelet volume in patients with acute coronary syndromes. Arch Pathol Lab Med. 2009;133:1441-1443.
24. Kayahan H, Akarsu M, Ozcan MA et al. Reticulated platelet levels in patients with ulcerative colitis. Int J Colorectal Dis. 2007;22:1429-1435.
25. Kapsoritakis AN, Koukourakis MI, Sfiridaki A et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol. 2001;96:776-781.